RESPIMAT® soft mist helps the patient get the medication deep into the lungs, without requiring a forceful inhalation1,4,7
Turn, Open, Press: RESPIMAT® in 2 puffs, once daily14§
Turn14
- Keep the cap closed
- TURN the clear base in the direction of the arrows on the label until you hear a click
Open14
- Flip the cap OPEN until it clicks into the open position
Press14
- Breathe out slowly and fully; then close your lips around the mouthpiece
- While taking in a slow, deep breath, PRESS the dose release button; keep breathing in slowly
- Close the cap
85%
of patients (N=7218, full analysis set) in the OTIVACTO real-world study were satisfied with inhalation from RESPIMAT®8
SPIOLTO® RESPIMAT® can provide benefits vs monotherapies beyond lung function9,10, including improvements in symptoms and overall health, relevant to COPD patients9
Learn more
Footnotes
- * In asthma patients—typical scintigraphic images in one patient comparing drug deposition profiles. Mean percentage of the dose deposited in the lungs of 14 asthma patients.3 For the comparison of RESPIMAT® vs TURBOHALER® with fast inhaled flow rate: p<0.001; BECLOFORTE® pMDI: p<0.001.3
-
Test drug inhaled:3
- From RESPIMAT® and TURBOHALER®: budesonide
- From pMDI: beclomethasone dipropionate
- † Results are based on an in vitro study. RESPIMAT® contained SPIRIVA® in an aqueous solution.6
- § For approved handling instructions, please refer to local package inserts.
References
- Anderson P et al. Int J Chron Obstruct Pulmon Dis. 2006;1(3):251-259.
- Zierenberg B. J Aerosol Med. 1999; 12(suppl 1):S19-S24.
- Pitcairn G et al. J Aerosol Med. 2005;18(3):264-272.
- Newman S et al. Chest. 1998;113(4):957–963.
- Haensel M et al. Adv Ther. 2019. DOI: 10.1007/s12325-019-01028-y.
- Ciciliani AM et al. Int J Chron Obstruct Pulmon Dis. 2017;12:1565-1577.
- Wachtel H et al. Pulm Ther. 2017;3:19-30.
- Valipour A et al. Int J Chron Obstruct Pulmon Dis. 2019;14:2343-2354.
- Ferguson GT et al. NPJ Prim Care Respir Med. 2017;27(1):7.
- Buhl R et al. Eur Respir J. 2015;45:969–979.
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease; updated 2020. Available at: https://goldcopd.org/wp-content/ uploads/2020-REPORTver1.0wms.pdf.
- Ghosh S et al. Int J Chron Obstruct Pulmon Dis. 2019;14:585-595.
- Loh CH et al. Ann Am Thorac Soc. 2017;14(8): 1305-1311.
- SPIOLTO® Respimat® Summary of Product Characteristics, March 2020.
